ursement set at a maximum 250 percent of AMP will lead to
reimbursements falling 36 percent below acquisition costs. Using a reduced
150 percent figure will likely cause reimbursement to fall more than 50
percent below the costs of the drugs themselves, without even considering
the cost to dispense drugs.
In a recent report, Stephen W. Schondelmeyer, PharmD, PhD, director of
the PRIME Institute at the University of Minnesota, provided dire warnings
about the effects of the previously adopted Medicaid cuts that have been
put on hold pending the results of litigation. Dr. Schondelmeyer indicated
the retail pharmacy industry could see a loss of 10,000-12,000 pharmacies.
The President's newest proposal only exacerbates the situation. While any
small business owner will tell you that running a business based on these
numbers is ruinous, the true victim of this policy will be the patient
whose access to prescription drugs will be limited.
The National Community Pharmacists Association, founded in 1898,
represents the nation's community pharmacists, including the owners of more
than 23,000 pharmacies. The nation's independent pharmacies, independent
pharmacy franchises, and independent chains dispense nearly half of the
nation's retail prescription medicines. To learn more go to
http://www.ncpanet.org.
'/>"/>SOURCE National Community Pharmacists Association Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse2.
Statement of the American Diabetes Association on the Administrations Proposal to Undermine Funds for Research, Prevention and Treatment in FY093.
NutraCea Files Universal Shelf Registration Statement4.
AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform5.
Statement by AARP CEO Bill Novelli on President Bushs State of the Union6.
Statement of Robert K. Ross, M.D.7.
NCPA Statement on Wal-Marts Entry Into the Pharmacy Benefit Market8.
Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering9.
Statement by Bruce Bodaken on Senate Health Committee Action10.
AASM statement on use of sleep medications11.
Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed